CAJ | 학술논문

原发性肝癌（ primary hepatocellular carcinoma，PHC）是我国最常见的恶性肿瘤之一，预后较差，多数患者就诊时已丧失手术机会。对于中晚期肝癌，目前采用放疗结合其他疗法，如放疗联合分子靶向药物治疗、放疗联合基因治疗和放疗联合中成药治疗等综合治疗手段使原发性肝癌的临床疗效有了一定的提高。
원발성간암（ primary hepatocellular carcinoma，PHC）시아국최상견적악성종류지일，예후교차，다수환자취진시이상실수술궤회。대우중만기간암，목전채용방료결합기타요법，여방료연합분자파향약물치료、방료연합기인치료화방료연합중성약치료등종합치료수단사원발성간암적림상료효유료일정적제고。
Primary hepatocellular carcinoma( PHC)is one of the most common malignant tumors in China with poor prognosis. Many patients have lost the operation chance. At present,the treatment of radiation combination therapy im-prove the clinical effect of advanced hepatocellular carcinom. The combination therapy,including radiotherapy com-bined molecular targeted therapy,gene therapy and proprietary Chinese medicine therapy,etc.